Summary The aim of this study was to elucidate the effects of dietary vitamin A and E supplementation on tumorigenesis in correlation to the fat content of the respective diet in an animal model. One hundred and twenty female SD rats were initiated intravenously with 25 mg MNU kg on day 50 of life. For a period of 6 months, beginning after the day of initiation, all animals received a semisynthetic diet containing 25% or 45% of the energy as fat, supplemented either with a 10-fold higher amount of naturally occurring vitamins A and E than in rat standard diets or, with a normal level of these vitamins.
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The experiment showed: (1) Vitamin A and E supplementation showed no significant chemopreventive effect against mammary tumour development. (2) This result was independent from the supplied fat level of the respective diet. (3) The fat content per se did not significantly influence mammary tumorigenesis.
In the last few years there has been a growing interest in the concept of cancer chemoprevention. The activities of several agents that appear to be useful in chemoprevention have been characterized, and there are continuing efforts to identify additional compounds, either of natural occurrence or synthetic, that can specifically inhibit the process of carcinogenesis.
During the early stages in the evolution of many neoplasms, metaplasia occurs. The normal differentiation pattern of the respective tissue is lost and a new form of epithelium appears. A deficiency of vitamin A, an essential agent to regulate cell proliferation and differentiation, results in metaplasia also (Cohen et al., 1976; Lotan, 1980 ; Moon et al., 1983) .
Experimental studies have indicated that insufficient dietary levels of vitamin A may be related to an increased susceptibility to carcinogen induced cancer of the stomach, nasopharynx, lower respiratory tract and endocervix (Moon et al., 1983; Romppanen et al., 1985) . Furthermore, there is evidence from some experimental results, that an increased intake of vitamin A or its synthetic analogues inhibits dimethylbenz(a)anthracene (DMBA)- (Clayson, 1975; McCormick et al., 1980; Stone et al., 1984) , methylnitrosourea (MNU)- (Moon et al., 1977; Welsch et al., 1980; Moon et al., 1983; McCormick & Moon, 1982) , and benzo(a)pyrene- (McCormick et al., 1981) induced rat mammary tumour development. The utility of vitamin A as an anticarcinogenic treatment, however, is contested in view of some experimental studies resulting in a zero effect (Schmahl et al., 1972; Schmahl & Habs, 1978; Thompson & Ronan, 1983) , or even an opposite effect (Polliack & Levij, 1969; Quander et al., 1985) , and in view of epidemiological findings. In man natural retinoids appeared to be associated with a lower risk of cancer of the lung (Shekelle et al., 1981) , urinary bladder, mouth, larynx, cervix, and to a lesser extent also of the breast (Kark et al., 1981; Graham, 1984) . One connecting link between all these tumours is their epithelial origin. Howeverm a higher risk from elevated retinoid levels was reported for prostate cancer, leukaemia and Hodgkin's disease (Graham, 1984 (Newberne & Suphakarn, 1983) . The influence of vitamin E on carcinogenesis, as determined by animal experiments, however, is not consistently beneficial in terms of cancer prevention (Shamberger & Rudolph, 1966; Wattenberg, 1972; Wattenberg, 1978; King & Otto, 1979; Ip, 1982a, b) . It is possible that vitamin E can inhibit chemically induced tumour development under certain conditions (Cook & McNamara, 1980; McCay et al., 1981) , but a reproducible experimental model in which vitamin E consistently suppresses neoplastic growth has not yet been found (McCay et al., 1981; Ip, 1982a, b) .
As found in a former experiment in our laboratories (Aksoy et al., 1985) both toxicity (bone fractures, loss of weight, peliosis cutis) and anti-tumour efficacy were found, when a high dose of vitamin A palmitate ester (100,000IU per 1,000kcal) was added to a diet containing a very low fat level of 12% of total energy as fat. However, in a high-fat group (45% energy as fat) neither toxicity nor tumourinhibitory activity following the same vitamin amounts were observed.
To elucidate this discrepancy we examined the influence of two levels of dietary fat in isocaloric diets, supplemented with normal or tenfold higher amounts of vitamins A (palmitate ester) and E on methylnitrosourea-induced rat mammary tumorigenesis. The (Table I ). The fat composition of semisynthetic diets (Table II) , which were obtained from Unilever Research (Vlaardingen, The Netherlands), was mixed according to the fatty acid profile of the normal Western German diet (normal diet = ND). Therefore, the fat of diets ND25 and ND45 (containing 25% and 45% of the energy as fat, respectively) consisted of 75% palm oil, 14% lard, and 11% sunflower seed oil. The ratio of saturated fatty acids and mono-and polyunsaturated fatty acids was 45%, 38% and 16%, respectively, in ND-diets. The supplemented vitamin diets (ND25 + A/E and ND45+A/E) contained 10 times more naturally occurring vitamins than the normal standard rat-diets, while remaining below the toxic level (50,000 IU vitamin A and 225 IU vitamin E per 1,000 kcal). The level of vitamin E was considered adequate in satisfying the vitamin requirements and preventing vitamin A oxidation in those rats fed a high fat and high vitamin containing diet (Table I) . Vitamin A was added to the diets as vitamin A palmitate. The diets were offered at a daily caloric supply of 50kcal per day and rat 5 times a week. On the fifth day a 3-fold amount was given. All fatty diets were kept in closed containers at -20°C to minimize lipid peroxidation. Before feeding the temperature of diets was brought up to room temperature. All animals received tap water ad libitum.
Evaluation of tumour growth and termination of study All animals were inspected twice daily. The body weight development and the occurrence and growth of mammary carcinomas was recorded in weekly intervals. The tumour size was estimated by measuring two vertical axes with vernier calipers according to the formula a2 x b/2(a <b). All animals were observed until termination of the study after 6 months of feeding, or were killed prematurely when found moribund. After death rats were dissected and macroscopically examined. All tumours and visibly changed organs were fixed in formalin for histological examination (Prof. D. Komitowsky, Institute of Pathology, German Cancer Research Center).
Statistical analysis
Estimates on the cumulative probability of tumour manifestation times were made using the Kaplan-Meier method; comparisons of censored animals between groups were made using the log-rank test (Kalbfleisch & Prentice, 1979) . Differences in tumour numbers were assessed according to Dunn's comparisons of multiple rank sums (Dunn, 1964) . Analysis of differential tumour growth was performed using a nonparametric multivariate test, as described by (Kalbfleisch & Prentice, 1979) .
Results
Body weight gain The effect of supplemented vitamins A and E to diets, different in the amount of fat, on the mean body weight gain of methylnitrosourea-induced female SD-rats is shown in Figure 1 . Aside from the small differences at the beginning of the experiment an almost congruent body weight gain could be observed. The number of tumours per group (Table III) is the result of ---.--.---------tumour incidence (Figure 2 ) and number of tumours per o ND 45 + A/E tumour bearing rat (Table III) Figure 2 Influence of vitamins A and E supplemented to diets containing two different fat levels on % tumour incidence (El) and % mortality (El) of methylnitrosourea induced female SDrats.
Development of tumour incidence and mortality Both the tumour incidence and mortality, due to tumour growth, increased slightly with rising fat content, which is shown in Figure 2 . This effect, however, was not significant. Supplementation of vitamin A and E had no homogeneous influence on the incidence of mammary tumours. In comparison to ND25 the ND25 + A/E-group showed a slight increase in the number of tumour bearing rats whereas in the groups receiving the diet with 45 en% of fat the vitamin supplementation decreased tumour incidence. These effects were not significant (Fishers Exact test). The diminishing effect of vitamin supplementation on mortality data was
Time (weeks) Figure 3 Tumour growth development of methylnitrosourea induced mammary carcinomas in SD-rats; comparison of the influence of two different fat levels with or without vitamin A and E supplementation. Indicated are the mean tumour volumes and selected 95% confidence limits of diets ND25 and ND45. 
Discussion
The present study was basically designed to elucidate the effects of dietary vitamin A and E supplementation on chemically induced mammary tumorigenesis and the variation in efficacy if these fat soluble vitamins are added to diets of different fat levels. The principal observations of this experiment are: (1) Vitamin A and E supplementation showed no significant chemopreventive effect against mammary tumour development. (2) This result was independent from the supplied fat level of the respective diet. (3) The fat content per se did not significantly influence mammary tumorigenesis.
The mammary gland is known to be a target organ of retinyl ester activity; according to Moon (1983) retinyl acetate exerts an inhibitory effect on ductal branching, end bud proliferation and DNA synthesis in this organ.
However, the utility of vitamin A as an anticarcinogenic treatment in mammary neoplasia is contested since some researchers found beneficial effects in MNU- (Moon et al., 1977) and in DMBA- (Welsch & De Hoog, 1983; Zile et al., 1986) induced mammary tumorigenesis. The reported significant decrease in body weight gain and the general unhealthy condition of the animals, however, lead to the conclusion, that the observed beneficial results must be regarded with consideration of the obvious toxic side effects in some of these studies (Welsch et al., 1980; McCormick & Moon, 1982; Thompson et al., 1986) .
In all of these studies vitamin A was administered as retinyl acetate. In this experiment, vitamin A was added to the diets as palmitate ester, because this form of vitamin A is the main source of dietary vitamin A intake in humans. Since retinyl esters, generally, are hydrolysed to retinol before being absorbed by intestinal mucosal cells, no difference in the released active vitamin has to be expected, regardless whether retinol, esterified to acetate or palmitate, is administered to the diet (Lotan, 1980) .
Other studies, which showed no significant effects on mammary tumorigenesis after vitamin A supplementation, administered either as palmitate ester (Schmahl et al., 1972) or as acetate ester (Thompson & Ronan, 1983) are in agreement with the results of the present experiment.
Remarkably, in addition to these findings, results from other tumour systems demonstrate even enhanced tumorigenesis following retinoid administration (Polliack & Levij, 1969; Quander et al., 1985) . The latter findings could raise concern about the potential hazard in the pharmacological use of vitamin A.
Concerning vitamin E our study corresponds with other experiments, which resulted in no beneficial effect on tumorigenesis (Shamberger & Rudolph, 1966; Wattenberg, 1972; King & Otto, 1979; Ip, 1982a, b) . Inhibitory effects on chemically induced tumour development was found only under certain conditions (Cook & McNamara, 1980; McCay et al., 1981) .
In a former experiment from our laboratory a high vitamin A palmitate supplementation, which was above the toxic level, decreased tumorigenesis, when given with a diet containing 12% energy as fat, only (Aksoy et al., 1985) . Although vitamin A toxicity and cancer preventive activity do not necessarily coincide, the tumour inhibitory effect as well as the toxic side effects were completely abolished, when vitamin A was supplemented to a high fat diet (45 en%). Similarly to this observation Aylsworth et al. (1986) found a significantly decreased tumour size after feeding retinyl acetate with a low fat diet, but no effect when supplementary to a high fat diet. As derived from these studies it seems that both the toxic side effects and the beneficial efficacy of vitamin A are dependent upon a low dietary fat level.
Because a fat content of 12 en% is not encountered in human diets, this study was set up to examine whether beneficial effects could be observed when the low fat level was adapted to the human situation and when the vitamin supplement was below the toxic level (50,000 IU per 1,000 kcal). Interestingly, the vitamin supplementation did not show a significant effect on tumorigenesis at either fat level.
Apart from this, the fat level per se did not show a significant effect on tumour development (Figure 2 , Table  III) , which is in full agreement with the results of a parallel study (Beth et al., 1987) .
Summarizing this discussion of the different experimental results we conclude that the naturally occurring vitamins A and E are not able to inhibit the process of carcinogenesis in the mammary gland specifically, except for very low dietary fat levels. Observed beneficial effects were connected with considerable toxic side effects of the compounds. An inhibitor of carcinogenesis, however, would have to be taken by individuals for many years. Thus even a low toxicity could outweigh any benefits. Therefore the ultimate goal of these experimental studies, to find a non-toxic pharmacological means which effectively inhibits the development of human mammary cancer, seems not to be reached with naturally occurring vitamins A and E at dietary fat levels encountered in human beings.
